Author:
Franchini Massimo,Focosi Daniele,Casadevall Arturo,Joyner Michael J.,Perotti Cesare
Reference10 articles.
1. Management of COVID patients with convalescent plasma: do we have the final word?;Menichetti;Eur J Intern Med,2021
2. Focosi D., Franchini M., Pirofski L., Burnouf T., Paneth N., Joyner M.J., Casadevall A. COVID-19 convalescent plasma and randomized clinical trials: rebuilding confidence by explaining failures and finding signals of efficacy. MedRxiv https://www.medrxiv.org/content/10.1101/2021.09.07.21263194v3.full.pdf+html 2021.
3. Effect of high-titer convalescent plasma on progression to severe respiratory failure or death in hospitalized patients with COVID-19 pneumonia: a randomized clinical trial;Menichetti;JAMA Netw Open.,2021
4. Agenzia Italiana del Farmaco (AIFA). https://www.aifa.gov.it/en/-/covid-19-studio-tsunami-il-plasma-non-riduce-il-rischio-di-peggioramento-respiratorio-o-morte (Published on 8 April 2021).
5. Italian society for transfusion medicine and immunohaematology (SIMTI), and the Italian society for haemapheresis and cell manipulation (SIdEM). position paper on the use of COVID-19 convalescent plasma: an update;Prati;Blood Transf,2021
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献